Award

2024A1515010330

Funder: Natural Science Foundation of Guangdong Province

Funded outputs count: 9

Funder award ID: 2024A1515010330

OpenAlex ID: G4639126293

TMEM72 Inhibits the proliferation by promoting cellular senescence through the activation of the P38/MAPK signaling pathway in renal cell carcinoma

2026 · Fang Dai, Huming Wang, et al. · Translational Oncology

Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms

2026 · Jie Wang, Ruicheng Wu, et al. · Cell Communication and Signaling · 3

The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis

2026 · Zhaojie Lyu, Yuhan Xiao, et al. · Frontiers in Immunology · 1

The Implications of Radiotherapy-Induced Cellular Senescence for Cancer Treatment and Tumor Microenvironment Modulation

2026 · Chao Jiang, Zhouting Tuo, et al. · International Journal of Biological Sciences · 6

NRF1 Induces ApoEhigh Cancer-Associated Fibroblasts to Promote Stemness of Renal Cell Carcinoma

2026 · Ying Zhang, Zhouting Tuo, et al. · Cancer Research · 4

Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer

2026 · Junjiang Ye, Yandong Xie, et al. · Research · 9

Pan-cancer analysis and experimental validation revealed the prognostic role of ZNF83 in renal and lung cancer cohorts

2025 · Peipei Wu, Yu Lin, et al. · Discover Oncology · 4

Identification and validation of SLC16A8 as a prognostic biomarker in clear cell renal cell carcinoma: a six-gene solute carrier signature

2025 · Hantao Wen, Fang Dai, et al. · Experimental Cell Research · 7

Increased ZNF83 is a potential prognostic biomarker and regulates oxidative stress-induced ferroptosis in clear cell renal cell carcinoma

2025 · Zhaojie Lyu, Huming Wang, et al. · Journal of Molecular Medicine · 7